The combination of initial markers to predict refractory Mycoplasma pneumoniae pneumonia in Chinese children: a case control study
- PMID: 33752670
- PMCID: PMC7983087
- DOI: 10.1186/s12931-020-01577-9
The combination of initial markers to predict refractory Mycoplasma pneumoniae pneumonia in Chinese children: a case control study
Abstract
Objective: Thise study is aimed to identify the biomarkers for predicting refractory Mycoplasma pneumoniae pneumonia in Chinese children at the time of the hospital admission.
Methods: The case control study retrospectively analyzed the clinical characteristics and laboratory results of Chinese pediatric patients presenting with common and refractory Mycoplasma pneumoniae pneumonia (CMPP and RMPP). Overall, there were 216 cases in the CMPP group and 88 cases in the RMPP group. Venous blood was collected, and serum ferritin (SF), lactate dehydrogenase (LDH), D-dimer, C-reactive protein (CRP), procalcitonin (PCT), neutrophil count/lymphocyte count (NLR), and other indexes were measured. A single factor analysis, an ROC curve analysis, and a logistic regression analysis were used to determine the independent risk factors of RMPP and find combination of initial markers for RMPP.
Results: There were significant differences between the RMPP group and the CMPP group in mean SF (529.82 [357.86] vs. 147.22 [122.68] ng/mL), LDH (522.08 [389.08] vs. 286.85 [101.02] U/L), D-dimer (6.65 [5.66] vs. 1.46 [2.45] μg/mL), CRP (62.80 [52.15] vs. 19.03 [24.50] mg/L), PCT (0.80 [2.61] vs. 0.16 [0.44]) ng/mL, and NLR (4.14 [2.52] vs. 2.62 [1.55]), with P < 0.05 for each comparison. ROC cut-off values of the above indexes were 329.01 ng/mL, 375.50 U/L, 2.10 μg/mL, 43.08 mg/L, 0.08 ng/mL, and 2.96, respectively. The logistic regression analysis showed that SF, D-dimer, and CRP are independent risk factors to predict RMPP.
Conclusion: SF, D-dimer, and CRP are statistically significant biomarkers to predict RMPP in Chinese children patients in the settings of pediatric emergency department.
Conflict of interest statement
The authors declare that they have no competing interests.
Figures


Similar articles
-
Clinical significance of D-dimer levels in refractory Mycoplasma pneumoniae pneumonia.BMC Infect Dis. 2021 Jan 6;21(1):14. doi: 10.1186/s12879-020-05700-5. BMC Infect Dis. 2021. PMID: 33407216 Free PMC article.
-
Genotyping and refractory risk factors of mycoplasma pneumoniae pneumonia in Suzhou, China.BMC Infect Dis. 2025 Apr 18;25(1):561. doi: 10.1186/s12879-025-10964-w. BMC Infect Dis. 2025. PMID: 40251512 Free PMC article.
-
[Clinical features and treatment of refractory Mycoplasma pneumoniae pneumonia unresponded to conventional dose methylprednisolone in children].Zhonghua Er Ke Za Zhi. 2014 Mar;52(3):172-6. Zhonghua Er Ke Za Zhi. 2014. PMID: 24824385 Chinese.
-
Refractory Mycoplasma Pneumonia in Children: A Systematic Review and Meta-analysis of Laboratory Features and Predictors.J Immunol Res. 2022 Jun 26;2022:9227838. doi: 10.1155/2022/9227838. eCollection 2022. J Immunol Res. 2022. PMID: 35795531 Free PMC article.
-
The risk factors of children acquiring refractory mycoplasma pneumoniae pneumonia: A meta-analysis.Medicine (Baltimore). 2021 Mar 19;100(11):e24894. doi: 10.1097/MD.0000000000024894. Medicine (Baltimore). 2021. PMID: 33725960 Free PMC article.
Cited by
-
Clinical characteristics and predictive indictors of macrolide-unresponsive Mycoplasma pneumoniae pneumonia in children: a retrospective study.Front Pediatr. 2024 Dec 3;12:1489389. doi: 10.3389/fped.2024.1489389. eCollection 2024. Front Pediatr. 2024. PMID: 39691386 Free PMC article.
-
Dose-response relationship and predictive value of soluble B7-DC in bronchoalveolar lavage fluid and risk of refractory Mycoplasma pneumoniae pneumonia in children.Kaohsiung J Med Sci. 2025 Apr;41(4):e12944. doi: 10.1002/kjm2.12944. Epub 2025 Feb 13. Kaohsiung J Med Sci. 2025. PMID: 39945309 Free PMC article.
-
Differences in pulmonary microbiota of severe community-acquired pneumonia with different pathogenic microorganisms in children.BMC Pediatr. 2025 Jun 3;25(1):449. doi: 10.1186/s12887-025-05819-x. BMC Pediatr. 2025. PMID: 40462041 Free PMC article.
-
Clinical features associated with macrolides resistance of Mycoplasma pneumoniae pneumonia in children: a single-center analysis.BMC Infect Dis. 2025 Jul 1;25(1):854. doi: 10.1186/s12879-025-11234-5. BMC Infect Dis. 2025. PMID: 40597734 Free PMC article.
-
Current Mycoplasma pneumoniae epidemic among children in Shanghai: unusual pneumonia caused by usual pathogen.World J Pediatr. 2024 Jan;20(1):5-10. doi: 10.1007/s12519-023-00793-9. Epub 2024 Jan 17. World J Pediatr. 2024. PMID: 38231466 No abstract available.
References
-
- Respiratory Section, Chinese Medical Association of Pediatrics. Expert consensus on diagnosis and treatment of Mycoplasma pneumoniae pneumonia in children. Chin J Pract Clin Pediatr. 2015;30(17):1304–08.
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous